• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于前列腺癌治疗的靶向PR_b的聚乙二醇化脂质体。

PR_b-targeted PEGylated liposomes for prostate cancer therapy.

作者信息

Demirgöz Döne, Garg Ashish, Kokkoli Efrosini

机构信息

Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis, Minnesota 55455, USA.

出版信息

Langmuir. 2008 Dec 2;24(23):13518-24. doi: 10.1021/la801961r.

DOI:10.1021/la801961r
PMID:18954096
Abstract

In recent years, there has been considerable effort in designing improved delivery systems by including site-directed surface ligands to further enhance their selective targeting. The goal of this study is to engineer alpha5beta1-targeted stealth liposomes (nanoparticles covered with poly(ethylene glycol) (PEG)) that will bind to alpha5beta1-expressing LNCaP human prostate cancer cells and efficiently release the encapsulated load intracellularly. For this purpose, liposomes (with and without PEG2000) were functionalized with a fibronectin-mimetic peptide (PR_b) and delivered to LNCaPs. The amount of PEG2000 and other liposomal components were characterized by 1H NMR, and the amount of peptide by the bicinchoninic acid protein assay. Fibronectin is the natural ligand for alpha5beta1, and a promising design for a fibronectinmimetic peptide includes both the primary binding site (RGD) and the synergy site (PHSRN) connected by a linker and extended off a surface by a spacer. We have previously designed a peptide-amphiphile, PRb, that employed a hydrophobic tail, connected to the N-terminus of a peptide headgroup composed of a spacer, the synergy site sequence, a linker mimicking both the distance and hydrophobicity/hydrophilicity present in the native protein fibronectin (thus presenting an overall "neutral" linker), and finally the primary binding sequence. We have examined different liposomal formulations, functionalized only with PR_b or with PR_b and PEG2000. For PR_b-targeted PEGylated liposomes, efficient cell binding was observed for peptide concentrations of 2 mol % and higher. When compared to GRGDSP-targeted stealth liposomes, PR_b functionalization was superior to that of GRGDSP as shown by increased LNCaP binding, internalization efficiency, as well as cytotoxicity after incubation of LNCaPs with tumor necrosis factor-alpha (TNFalpha)-encapsulated liposomes. More importantly, PR_b is alpha5beta1-specific, whereas many integrins bind to small RGD peptides. Thus, the proposed PR_b-targeted delivery system has the potential to deliver a therapeutic payload to prostate cancer cells in an efficient and specific manner.

摘要

近年来,人们付出了巨大努力来设计改进的递送系统,通过引入位点特异性表面配体来进一步增强其选择性靶向性。本研究的目的是构建靶向α5β1的隐形脂质体(覆盖有聚乙二醇(PEG)的纳米颗粒),使其能够与表达α5β1的LNCaP人前列腺癌细胞结合,并在细胞内有效释放包封的物质。为此,用纤连蛋白模拟肽(PR_b)对脂质体(有或没有PEG2000)进行功能化修饰,并递送至LNCaP细胞。通过1H NMR表征PEG2000和其他脂质体成分的量,通过二辛可宁酸蛋白测定法测定肽的量。纤连蛋白是α5β1的天然配体,一种有前景的纤连蛋白模拟肽设计包括通过连接体连接的主要结合位点(RGD)和协同位点(PHSRN),并通过间隔基团从表面延伸出来。我们之前设计了一种肽两亲分子PRb,它采用疏水尾部,连接到由间隔基团、协同位点序列、模拟天然蛋白纤连蛋白中存在的距离和疏水性/亲水性的连接体(从而呈现出整体“中性”连接体)以及最终的主要结合序列组成的肽头基的N端。我们研究了仅用PR_b或用PR_b和PEG2000功能化修饰的不同脂质体制剂。对于PR_b靶向的聚乙二醇化脂质体,当肽浓度为2 mol%及更高时,观察到有效的细胞结合。与GRGDSP靶向的隐形脂质体相比,PR_b功能化在LNCaP结合、内化效率以及用包封肿瘤坏死因子-α(TNFα)的脂质体孵育LNCaP细胞后的细胞毒性方面均优于GRGDSP。更重要的是,PR_b是α5β1特异性的,而许多整合素与小的RGD肽结合。因此,所提出的PR_b靶向递送系统有潜力以高效且特异的方式将治疗性物质递送至前列腺癌细胞。

相似文献

1
PR_b-targeted PEGylated liposomes for prostate cancer therapy.用于前列腺癌治疗的靶向PR_b的聚乙二醇化脂质体。
Langmuir. 2008 Dec 2;24(23):13518-24. doi: 10.1021/la801961r.
2
Effect of linker and spacer on the design of a fibronectin-mimetic peptide evaluated via cell studies and AFM adhesion forces.通过细胞研究和原子力显微镜粘附力评估接头和间隔臂对纤连蛋白模拟肽设计的影响。
Langmuir. 2008 Sep 16;24(18):10282-92. doi: 10.1021/la702434p. Epub 2008 Aug 12.
3
PEGylated liposomal doxorubicin targeted to α5β1-expressing MDA-MB-231 breast cancer cells.靶向表达 α5β1 的 MDA-MB-231 乳腺癌细胞的 PEG 化脂质体阿霉素。
Langmuir. 2012 Mar 13;28(10):4729-36. doi: 10.1021/la204466g. Epub 2012 Feb 29.
4
Targeting colon cancer cells using PEGylated liposomes modified with a fibronectin-mimetic peptide.使用经纤连蛋白模拟肽修饰的聚乙二醇化脂质体靶向结肠癌细胞。
Int J Pharm. 2009 Jan 21;366(1-2):201-10. doi: 10.1016/j.ijpharm.2008.09.016. Epub 2008 Sep 19.
5
Enhanced integrin mediated signaling and cell cycle progression on fibronectin mimetic peptide amphiphile monolayers.在纤维连接蛋白模拟肽两亲单层上增强整合素介导的信号转导和细胞周期进程。
Langmuir. 2012 Jan 24;28(3):1858-65. doi: 10.1021/la203322t. Epub 2012 Jan 9.
6
pH-Sensitive PEGylated liposomes functionalized with a fibronectin-mimetic peptide show enhanced intracellular delivery to colon cancer cell.pH 敏感的 PEGylated 脂质体通过纤维连接蛋白模拟肽进行功能化,可增强对结肠癌细胞的细胞内递送。
Curr Pharm Biotechnol. 2011 Aug;12(8):1135-43. doi: 10.2174/138920111796117328.
7
Modification of the C16Y peptide on nanoparticles is an effective approach to target endothelial and cancer cells via the integrin receptor.在纳米颗粒上修饰 C16Y 肽是通过整合素受体靶向内皮细胞和癌细胞的有效方法。
Int J Pharm. 2012 May 30;428(1-2):114-7. doi: 10.1016/j.ijpharm.2012.02.006. Epub 2012 Mar 6.
8
Targeted lipid-coated nanoparticles: delivery of tumor necrosis factor-functionalized particles to tumor cells.靶向脂质包被纳米颗粒:将肿瘤坏死因子功能化颗粒递送至肿瘤细胞
J Control Release. 2009 Jul 1;137(1):69-77. doi: 10.1016/j.jconrel.2009.03.010. Epub 2009 Mar 21.
9
Dual-ligand αβ and αβ integrin targeting enhances gene delivery and selectivity to cancer cells.双配体 αβ 和 αβ 整联蛋白靶向增强基因向癌细胞的传递和选择性。
J Control Release. 2017 Apr 10;251:24-36. doi: 10.1016/j.jconrel.2017.02.017. Epub 2017 Feb 17.
10
Biomimetic peptide-amphiphiles for functional biomaterials: the role of GRGDSP and PHSRN.用于功能性生物材料的仿生肽两亲分子:GRGDSP和PHSRN的作用。
Biomacromolecules. 2004 May-Jun;5(3):950-7. doi: 10.1021/bm0344351.

引用本文的文献

1
Local, Sustained, and Targeted Co-Delivery of MEK Inhibitor and Doxorubicin Inhibits Tumor Progression in E-Cadherin-Positive Breast Cancer.MEK抑制剂与阿霉素的局部、持续和靶向共递送抑制E-钙黏蛋白阳性乳腺癌的肿瘤进展。
Pharmaceutics. 2024 Jul 25;16(8):981. doi: 10.3390/pharmaceutics16080981.
2
Co-Delivery of Valsartan and Metformin from a Thermosensitive Hydrogel-Nanoparticle System Promotes Collagen Production in Proliferating and Senescent Primary Human Dermal Fibroblasts.温敏水凝胶-纳米粒子系统共递送缬沙坦和二甲双胍促进原代人真皮成纤维细胞增殖和衰老时胶原的产生。
Biomacromolecules. 2024 Sep 9;25(9):5702-5717. doi: 10.1021/acs.biomac.3c01461. Epub 2024 Aug 26.
3
Research Advances of Lipid Nanoparticles in the Treatment of Colorectal Cancer.
脂质纳米粒在结直肠癌治疗中的研究进展。
Int J Nanomedicine. 2024 Jul 3;19:6693-6715. doi: 10.2147/IJN.S466490. eCollection 2024.
4
Polymersome-based protein drug delivery - quo vadis?基于聚合物囊泡的蛋白药物递送——路在何方?
Chem Soc Rev. 2023 Jan 25;52(2):728-778. doi: 10.1039/d2cs00106c.
5
Ligand-Specific Nano-Contrast Agents Promote Enhanced Breast Cancer CT Detection at 0.5 mg Au.配体特异性纳米对比剂在 0.5mg Au 水平促进增强型乳腺癌 CT 检测
Int J Mol Sci. 2022 Sep 1;23(17):9926. doi: 10.3390/ijms23179926.
6
Liposomal delivery of CRISPR/Cas9.脂质体递送 CRISPR/Cas9。
Cancer Gene Ther. 2020 Aug;27(7-8):515-527. doi: 10.1038/s41417-019-0141-7. Epub 2019 Nov 2.
7
Effect of PEGylation on Ligand-Targeted Magnetoliposomes: A Missed Goal.聚乙二醇化对配体靶向磁脂质体的影响:一个未达成的目标。
ACS Omega. 2017 Oct 31;2(10):6544-6555. doi: 10.1021/acsomega.7b00778. Epub 2017 Oct 9.
8
Chemodrug delivery using integrin-targeted PLGA-Chitosan nanoparticle for lung cancer therapy.整合素靶向 PLGA-壳聚糖纳米粒递药用于肺癌治疗。
Sci Rep. 2017 Nov 7;7(1):14674. doi: 10.1038/s41598-017-15012-5.
9
Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come.癌症治疗中的脂质基药物递送系统:现状与未来展望
Pharmacol Rev. 2016 Jul;68(3):701-87. doi: 10.1124/pr.115.012070.
10
Physical chemistry of nanomedicine: understanding the complex behaviors of nanoparticles in vivo.纳米医学的物理化学:理解纳米颗粒在体内的复杂行为
Annu Rev Phys Chem. 2015 Apr;66:521-47. doi: 10.1146/annurev-physchem-040513-103718. Epub 2015 Jan 19.